Grief, Psychedelics, and Hypnosis: A Personal Perspective
$65.00
Presented by David Patterson, PhD, ABPP, ABPH
Recorded on Friday, October 11, 2024
Access provided upon registration on “My Courses” page
This webinar will discuss rapidly increasing use of psychedelics in psychotherapy, particularly psilocybin and MDMA, the application of these therapies to treating complicated grief, and how hypnosis is related to this new wave of therapies. The presenter has been a medical school-based psychology professor with an expertise in behavioral medicine and hypnosis for 40 years. The webinar will describe how the presenter became familiar with psychedelic therapies as on options for his terminally ill patients. We will then discuss how, after losing his 26-year-old son, the presenter turned to psychedelic therapies to manage his psychological challenges. In the course of undergoing psychedelic assisted psychotherapy himself, the presenter was able to realize how many parallels there were between the work he had been doing with the unconscious in hypnosis and psychotherapy and these innovative treatments. An example of this is the positive unconscious and the notion of creating a response set in psychotherapy that is internally generated by the patient, rather than structured by the therapist. In conducting this webinar, the presenter will review the literature on psychopharmacology of the psychedelic therapies discussed, as well as the clinical research associated with their efficacy. This course will be partially based on the 2nd edition of Clinical Hypnosis for Pain Control, American Psychological Association by D. R. Patterson and E. M. Mendoza.
Description
Presented by David Patterson, PhD, ABPP, ABPH
Recorded on Friday, October 11, 2024
Access provided upon registration on “My Courses” page
This webinar will discuss rapidly increasing use of psychedelics in psychotherapy, particularly psilocybin and MDMA, the application of these therapies to treating complicated grief, and how hypnosis is related to this new wave of therapies. The presenter has been a medical school-based psychology professor with an expertise in behavioral medicine and hypnosis for 40 years. The webinar will describe how the presenter became familiar with psychedelic therapies as on options for his terminally ill patients. We will then discuss how, after losing his 26-year-old son, the presenter turned to psychedelic therapies to manage his psychological challenges. In the course of undergoing psychedelic assisted psychotherapy himself, the presenter was able to realize how many parallels there were between the work he had been doing with the unconscious in hypnosis and psychotherapy and these innovative treatments. An example of this is the positive unconscious and the notion of creating a response set in psychotherapy that is internally generated by the patient, rather than structured by the therapist. In conducting this webinar, the presenter will review the literature on psychopharmacology of the psychedelic therapies discussed, as well as the clinical research associated with their efficacy. This course will be partially based on the 2nd edition of Clinical Hypnosis for Pain Control, American Psychological Association by D. R. Patterson and E. M. Mendoza.